Research and Markets has announced the addition of the "Mitogen Activated Protein Kinase 14 - Pipeline Review, H2 2016" report to their offering.
Mitogen Activated Protein Kinase 14 pipeline Target constitutes close to 13 molecules.
Out of which approximately 11 molecules are developed by Companies and remaining by the Universities/Institutes. Our latest report Mitogen Activated Protein Kinase 14 - Pipeline Review, H2 2016, outlays comprehensive information on the Mitogen Activated Protein Kinase 14 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type.
Mitogen Activated Protein Kinase 14 Mitogen-activated protein kinase 14 also called p38-alpha is an enzyme belongs to p38 MAPK family. p38-alpha MAPK play an important role in the cascades of cellular responses evoked by extracellular stimuli such as proinflammatory cytokines or physical stress leading to direct activation of transcription factors. p38-alpha MAPK is expressed in many cell types. p38-alpha MAPK is implicated in cell apoptosis, proliferation, differentiation, migration, mRNA stability, and inflammatory response in different cell types through variety of different target molecules. The molecules developed by Companies in Phase II, Preclinical and Discovery stages are 5, 4 and 2 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 1 and 1 molecules, respectively.
Furthermore, this report also reviews key players involved in Mitogen Activated Protein Kinase 14 targeted therapeutics development, features dormant and discontinued projects and latest news and press releases.
Key Topics Covered:
For more information about this report visit http://www.researchandmarkets.com/research/phstbt/mitogen_activated
View source version on businesswire.com: http://www.businesswire.com/news/home/20161020006419/en/Business Wire
Last updated on: 20/10/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.